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Oral fast-dispersible film was prepared by utlizing donepezil hydrochloride (drug) and 
various cellulose derivatives such as hydroxypropyl methyl cellulose (hypermellose) (HPMC), 
microcrystalline cellulose (MCC) and nanocrystalline cellulose (NCC) to treat Alzheimer’s disease. 
NCC was synthesized by ultra-sonication method using MCC and this was converted to thinfilm 
formulation (NCC-F) using solvent casting technique. The interaction between the polymer and the 
drug was investigated by spectral analysis such as UV, FTIR, and 1H- NMR. FTIR confirmed that 
the compatibility of drug and polymer in ODF formulation. NCC-F has shown an average surface 
roughness of 77.04 nm from AFM and the average particle size of 300 nm from SEM analysis. Nano 
sized particle of NCC-F leads faster in vitro dissolution rate (94.53%) when compared with MCC-F 
and F3 formulation. Animal model (in vivo) studies of NCC-F formulation has reached peak plasma 
concentration (C
max
) up to 19.018 ng/mL in the span of (t
max
) 4 h with greater relative bioavailability 
of 143.1%. These results suggested that high surface roughness with nanosized NCC-F formulation 
attained extended drug availability up to (t
1/2
) 70 h.
Keywords: Oral dispersible film. Nanocrystalline cellulose. Ultrasonication. 3D atomic force 
microscopy. Donepezil. Solvent casting. Alzheimer’s disease.
INTRODUCTION
Cellulose is widely used biopolymer on the earth 
which has linked with β-1, 4-D glucose molecules of a 
homopolymer. Nano crystalline cellulose is a preferable 
polymer to combine with external moiety through 
hydrogen bonding to form nano-sized composites. 
Many literatures are published on extraction of nano-
sized cellulose from various chemical and mechanical 
sources for the removal of amorphous part of cellulose 
using strong acid hydrolysis which results cellulose 
nanocrystals (Tang et al., 2013). Cellulose nanoparticles 
was prepared from joint chemical treatment with high-
intensity ultrasonication (Chen et al., 2011). Based 
on environmental concern, nano sized cellulose was 
prepared to use high-cost alternative methods such 
as acid hydrolysis, ultrasonication, and TEMPO- 
mediated oxidation process (De Campos et al., 2013). 
Nanocrystalline cellulose was used to control the drug 
releasing behavior by binding with an active drug moiety 
(Letchford et al., 2011). 
Alzheimer’s disease (AD) is a progressive 
neurodegenerative disorder (Bartha et al., 2007; Brendan 
et al., 2007) in which patients typically lose cognitive 
faculties, struggle to carry out activities of daily living and 
experiencing behavioural and neuropsychiatric problems 
(Hebert et al., 2003). The frequency of AD increases with 
age and it affects mainly 65-85 age of people (Molinuevo 
et al., 2011). At present, there is no curative treatment way 
for this entity. Currently, there are two types of drugs 
approved for the symptomatic treatment of patients with 
AD, the cholinesterase inhibitors (donepezil, galantamine, 
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and rivastigmine) and memantine, an antagonist of 
N-methyl d-aspartate (Atri et al., 2013). After randomized 
clinical trials of lasting for 6 months, donepezil is approved 
for all stages of AD in US and Japan (Cheewakriengkrai, 
Gauthier, 2013). Though, an effective drug, bitter in 
taste (Lange, Speight, 2005) elder patients find much 
more difficulty in swallowing the available conventional 
dosage forms like tablets and capsules. To overcome these 
problems from the patients, oral disintegrating dosage 
film formulation has been found. This is a safe, most 
convenient and cost-effective method of drug formulation 
with large patient compliance.
The orodispersible films (ODF) was much familiar 
as an alternative to commercial delivery form in the 
1970s (Dixit, Puthli, 2009). On the other hand, the oral 
disintegrating film is a thin, flexible and transparent 
strip containing biodegradable and highly hydrophilic 
polymers, which dissolve quickly on exposure to 
saliva and disintegrated in the buccal cavity by itself 
(Abdelbary et al., 2005). To produce thin film, the acrylic 
and cellulosic polymers like hydroxyl propyl cellulose 
(HPC) and hydroxyl propyl methyl cellulose (HPMC) 
have been used through hot melt extrusion technology. 
The obtained film should qualify all evaluation limits 
from the process of formulation for the transportation.
Ease of administration is of paramount importance 
for the dosage forms, especially among patient suffering 
from schizophrenia, bipolar disorder, Parkinson’s 
disease and Alzheimer disease (Rocca et al., 2002; 
Rogers et al., 1998). Taste-masked oral disintegrating 
film was developed which contain donepezil for the 
treatment of Alzheimer’s disease (Nishimura et al., 
2009). Earlier preparation includes oral disintegrating 
film having prochlorperazine, a dopamine D2 receptor 
antagonist with anti-emetic property using cellulose as 
the base materials. 
Present work deals with the preparation of donepezil 
oral disintegrating thinfilms (ODF) with different 
cellulose derivatives like HPMC, MCC, and NCC. 
Preparation of nanocrystalline cellulose was achieved 
by ultrasonication followed by centrifugation process 
from MCC. The phenomenon of making thin ODF was 
materialized by solvent casting technique and exhibited 
spectral characteristics like UV, FT-IR, and 1H-NMR 
respectively for desired formulations. Morphology and 
particle size were examined by AFM and SEM. In vitro 
and In vivo drug release profile was highlighted for 
NCC-F formulation with valid details and compared 
with other formulation (MCC-F and HPMC).
EXPERIMENTAL PART
Material and Methods
Donepezil hydrochloride was received as a gift 
sample from Dr Reddys laboratory (Hyderabad, 
India). Hydroxy propyl methyl cellulose 3cps and 
5cps (hypermellose) (HPMC), micro crystalline 
cellulose (MCC) and carboxy methyl cellulose sodium 
(CMC sodium) were purchased from Sigma Aldrich., 
(Bangalore, India). Acesulfame was received from Avra 
Synthesis Pvt Ltd., (Hyderabad, India). Polyethylene 
glycol-600 (PEG) was obtained from SD Fine Chemicals 
Ltd., (Chennai, India). Phosphate buffer salt (pH 6.8) 
was purchased from Fisher Chemicals., (Chennai, 
India). Oral disintegrating tablet (Aricept ®) was used 
for in vitro and in vivo animal study.
Preparation of nanocrystalline cellulose (NCC)
Microcrystalline cellulose (MCC) was used for the 
preparation of nanocrystalline cellulose (NCC) using 
ultrsonication process (Garvie-Cook et al., 2015). Firstly 
1 g of MCC was taken in 250 mL of distilled water in a 
beaker and swelled for 24 h. This was ultrasonicated at 
1500 W output in three different time points 5, 10 and 25 
min. After this process, the formed suspension underwent 
for centrifugation process at 2000 rpm and 4000 rpm for 
10 min each, the obtained supernatant layer was collected, 
freeze-dried and stored at 5 ºC for further analysis.
Preparation of orodispersible film (ODF)
Total five different types of ODF formulations were 
prepared by solvent casting technique using HPMC 
3cps and the drug (F1), HPMC 5cps with the drug (F2), 
HPMC 5 cps combined with carboxy methylcellulose 
sodium (F3), MCC-F and NCC-F. All the formulation 
were represented in Table I. PEG was used as a film 
former in the preparation and acesulfame was a calorie-
free sweetener which used as taste masking agent in the 
formulation. The active ingredient (drug) was dissolved 
in 10 mL of distilled water and stirred for 30 min until it 
gets clear liquid. On the other hand, cellulose constituents, 
PEG, glycerol, and acesulfame was homogenized over 30 
min. Finally, drug was mixed with polymer solutions and 
stirred at 1500 rpm for an 30 min. This was allowed for 
sonication about 15 min to remove entrapped air bubbles 
inside the formulation. The final solution was transferred 
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into a petri plate diameter of 8×8 cm2 and was maintained 
at room temperature for 24 h. The formed film was 
carefully removed from the petri plate and cropped into 
2×2 cm2 in size. The film was further examined for its 
physical characterization. Glycerol help to recover the 
final film from the petri plate. The schematic diagram of 
the preparation process is shown in scheme 1.





F1 F2 F3 MCC-F NCC-F
Drug 5 5 5 5 5 
HPMC 3cps 45 - - - -
(continuing)





F1 F2 F3 MCC-F NCC-F
MCC 45 -
NCC-25 min - - - - 45 
HPMC 5cps - 45 40 - -
CMC sodium - - 5 - -
PEG-600 12 12 12 12 12 
Glycerol 2 2 2 2 2 
Acesulfame 1 1 1 1 1 
Water 15 mL 15 mL 15 mL 15 mL 15 mL
SCHEME 1 - Schematic representation about the preparation of cellulose based ODF.
Spectral Characterization
Fourier transform infrared (FTIR) spectra 
was recorded using Thermo Nicolet 330 FTIR 
spectrophotometer. This was used to determine 
compatibility between polymer and drug in the ODF 
formulation in the range of 500-4000 cm-1 using KBR 
pellet. 1H NMR spectra of oral thin film were recorded 
with Bruker AVANCE III 400 MHz using deuterated water 
(D2O) as a solvent. Absorption studies were conducted 
by Hitachi U2910 Ultra-violet (UV) spectrophotometer. 
Thermo gravimetric analysis (TGA) was carried out 
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on TA -dynamic TGA 2950 by maintaining nitrogen 
atmosphere at a heating rate of 10 ºC. Nano surf easy 
scan-II atomic force microscopy (AFM) instrument was 
used to characterize surface morphology. Film size of 2 
× 2 cm2 was allowed to expose in five different locations 
(centre and four corners). The surface was imaged by 
tapping mode to elucidate mean roughness. Small pieces 
of the film was scanned by placing them on a metal stub 
with a double-sided adhesive layer using Zeiss scanning 
electron microscope (SEM). Particle size was measured 
using HORIBA SZ-100 (Japan) dynamic light scattering 
(DLS) at 25 ºC. Each sample was dissolved in 10 mL 
deionised water and allowed to run for 3 times using 
DLS instrument to find Poly dispersity index (PDI) and 
peak value of particle diameter (nm).
Evaluation parameters of the film
Five different formulations of drug-loaded 
cellulose thin film (F1-F3), MCC-F and NCC-F were 
tested for their visual inspection like appearance, 
cracks, entrapment of air bubbles inside the film, colour 
and stickiness of film to petri plate. Surface pH was 
measured by placing the electrode on a wet film to find 
the nature (acidity/alkalinity) of ODF surface. The film 
thickness is a basic criteria to conclude uniformity at 
its given strength and measured by Vernier callipers. 
Thickness was measured in five different locations 
(centre and four corners) of the film and mean thickness 
was calculated. The ODF formulation was repeatedly 
folded at a point until crack and the total number of folds 
considered as the value of its folding endurance (Rao, 
Diwan, 1998). Disintegration studies were performed 
by electro lab disintegration tester using phosphate 
buffer (pH=6.8) at 37.0 ± 0.5 ª C.
Uniformity of dosage measurement
Dosage uniformity was determined by high-
performance liquid chromatography (HPLC) with 
spectrometric detection, according to Japanese 
Pharmacopeia 15th edition. Acceptance value (AV) for 
the preparation must be less than 15% and calculated by 
following equation (Kumar et al., 2014). 
Where M refers to label claim (100%), X is for 
average (%) of each content, k is the acceptability 
constant (2.2), s refers to standard deviation.
According to United States Pharmacopeia 
31, 2010, (Koch et al., 2010) amount of drug in the 
formulation should be 90 – 110% and relative standard 
deviation should be less than or equal to 6%. A strip 
of Donepezil oral thin film (5 mg) was dissolved in 
100 mL of 50% methanol solution. 20 µL of sample 
were injected into HPLC and symmetrical C18 
column was employed to estimate the amount of drug. 
The stability test was determined by storage time in 
ambient conditions. A small piece of ODF (2×2 cm2) 
was taken in an aluminium foil and allowed to store for 
2-12 weeks at 40 ºC temperature with 75% humidity 
(accelerated condition) to find stability under ambient 
conditions.
Statistical analysis
All the obtained data were expressed as the mean ± 
SD. All the physical evaluations and dissolutions study, 
all the data were compared statistically. In vitro data 
of all the formulations were compared and evaluated 
statistically by Higuchi model and Kosmeyer- Peppas 
equation (Shoaib et al., 2006).
In-Vitro drug dissolution analysis
In-Vitro drug dissolution study was carried out 
using type-II USP dissolution apparatus and pH 7.4 
phosphate buffer as dissolution medium with the 900 
mL bath volume. The dissolution test was carried out 
at 50 rpm at 37 ±0.5 ºC. The prepared ODF was cut in 
to a size of 2×2 cm2 and placed in a dissolution basket 
contains phosphate buffer medium. 5 mL of sample 
was taken at specific time intervals (0-2 h). An equal 
volume of the dissolution medium was replaced in the 
vessel after taking sample to maintain sink condition. 
The concentration of the drug was determined by UV-
Vis spectrophotometer at 232 nm (λ max of Donepezil 
hydrochloride). The percentage of drug release at 
various time intervals was calculated and plotted against 
time intervals.
In vivo animal studies
Animal’s studies were carried out using Albino 
Wister rats of 12 to 14 weeks (200 to 300 g). These rats 
were maintained with proper diet and stable conditions 
(12 h light/dark at 24±5 ºC). Operating procedure 
and experiments were approved by the Institutional 
ethical committee, VIT University, India. Rats were 
administered at 5 mg/kg dose of drug via oral route 
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and observed for complete degradation of drug in oral 
cavity. Experimental rats were anesthetized at least 
2 to 3 min before taking blood samples. Sampling 
procedure was operated by rupturing the orbital 
plexus of rat in different time intervals starting from 
3 min, 10 min, 15 min, 30 min, and 1 h to 24 h after 
the administration of drug. Further blood samples 
were collected in heparinized tubes and samples 
were continued for the centrifugation at 10,000 rpm 
for 5 min. The plasma was separated and stored at 
-40 to -70 ºC for further analysis. Plasma samples 
of each interval were assayed by high performance 
liquid chromatography (HPLC) method to obtain 
pharmacokinetic parameters. The HPLC assay was 
estimated using Waters 1525 instrument (Waters2695 
Alliance,USA) with wavelength (λ) detection (190 - 
700 nm). Mobile phase consists of 60% methanol, 40% 
0.02 M phosphate buffer and 0.5% of triethylamine. 
Column used was symmetrical C18 (5µm 4.6 × 150 mm) 
and temperature was set to be 40 ºC. All the parameters 
were calculated by non-compartmental assay using a 
computer software program (WinOnline1). The peak 
plasma concentration Cmax (ng/mL) with respective 
time bound tmax (h) was evaluated (Sayed et al., 2013). 
Total drug available throughout the study period and 
relative bioavailability was calculated from area under 
curve (AUC (0-∞)). The AUC plasma concentration 
for 24 h (AUC(0-24)) upto infinity (AUC(0-∞)) was 
measured by trapezoid method with mean ± SD and 
statistical significance (p≤0.05).
RESULTS AND DISCUSSION
Fast dissolving orodispersible film (ODF) was 
prepared by solvent casting technique using Donepezil 
hydrochloride as a drug and cellulose derivatives as a 
polymer for the treatment of Alzheimer disease. The 
film was characterized using UV, FTIR, and NMR 
spectrophotometer.
Physical characteristics of ODF formulations
ODF formulations were evaluated for their physical 
characteristics, which is mentioned in Table II. All 
the formulations were appeared to be transparent and 
translucent for naked eye visuals. Optimum thickness 
of all formulations were found to be 220 µm. The 
mechanical strength of ODF formulations was revealed 
by folding endurance that was 34 to 43. Drug content of 
all the formulations were examined which was agreed 
well with the standard data of acceptance value (13.8%). 
The surface pH of ODF was found to be neutral for all 
formulations and this was safe for oral mucosa (Liew 
 et al., 2011). Initially, disintegration time was 13 sec and 
complete disappearance of the particles in the solution 
was observed at 42 sec for NCC formulations. These 
obtained results were ideal for rapid disintegration 
phenomena and help to promote the onset of drug 
releasing action (Yamamoto et al., 2009). From the 
stability measurements (2-12 weeks), the percentage 
of donepezil hydrochloride was observed to be 95.5% 













F1 0.21 ± 0.5 33.29 ± 1.05 6.8 ± 0.25 22.54 ± 1.15 translucent 35 ± 0.05
F2 0.22 ± 0.5 35.58 ± 1.07 6.8 ± 0.45 20.58 ± 1.07 translucent 45 ± 0.5
F3 0.22 ± 0.5 39.45 ± 1.04 6.9 ± 0.01 21.45 ± 1.24 translucent 50 ± 0.49
MCC-F 0.22 ± 05 37.77 ± 1.05 6.8 ± 0.05 25.88 ± 1.05 translucent 46 ± 0.05
NCC-F 0.21 ± 0.5 42.73 ±1.05 6.8 ± 0.05 22.73 ± 1.5 translucent 42 ± 0.5
Note: All experiments were done in triplicate; P value of less than 0.05.
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to 99.1%. Physical evaluations of all the formulations 
were showed acceptable results for desired drug release 
(Saluja et al., 2013).
Spectral evaluations of ODF
UV spectra of drug and ODF formulations were 
shown in Figure 1. From the UV spectra of the drug, the 
broad absorption peak was formed at 232 and 320 nm. 
This was shifted to 230-235 and 315-320 nm in the ODF 
which was responsible for π-π* transition occurred in 
aromatic conjugates of the drug. This was confirmed that 
the presence of drug in the formulated ODF. Maximum 
absorption wavelength for the drug (232 nm) was taken 
for further drug dissolution studies.
FT-IR was carried out to identify the functional 
groups and its characteristic vibrations involved in oral 
thin film formulations (Shen et al., 2013). The FTIR 
spectrum of ODF formulation (F2, F3) was shown in 
Figure 2. The F2 and F3 formulated films were showed 
broad peak at 3328 and 3365 cm -1 that was assigned to 
O-H stretching vibration for the cellulose polymer. The 
C=O stretching peak was clearly observed in 1681 cm-1 
for pure drug molecules. C-H stretching vibration was 
seen at 2890-2922 cm-1 and C-N stretching of tertiary 
amine has appeared at 1315-1265 cm-1. Considering 
all these results, there could be possible of hydrogen 
bond interactions between drug and polymer. The 
intensity of donepezil hydrochloride was decreased 
after formulation due to the electrostatic interaction 
between drug and polymer which allows a high degree 
of dissolution. Figure 3 represents the 1H NMR spectra 
of F2 and F3 ODF formulation. Two parts of peak 
signal were observed for the ODF formulation (F2 and 
F3). Former part was assigned for the OH contained 
polymer and was found at a region of 4.7 ppm. Later 
part was ascribed for the aromatic and alkyl protons 
of the drug which was observed at 7.24 ppm and 2.7-
3.7 ppm respectively. The presence of another band at 
2.15 ppm was due to acetyl protons which was present 
in the ODF (F2 and F3). These results confirm that the 
drug and polymer interacted with hydrogen bonding to 
enable the drug to release quickly and may aim for rapid 
disintegration (Song et al., 2015).













F1 0.21 ± 0.5 33.29 ± 1.05 6.8 ± 0.25 22.54 ± 1.15 translucent 35 ± 0.05
F2 0.22 ± 0.5 35.58 ± 1.07 6.8 ± 0.45 20.58 ± 1.07 translucent 45 ± 0.5
F3 0.22 ± 0.5 39.45 ± 1.04 6.9 ± 0.01 21.45 ± 1.24 translucent 50 ± 0.49
MCC-F 0.22 ± 05 37.77 ± 1.05 6.8 ± 0.05 25.88 ± 1.05 translucent 46 ± 0.05
NCC-F 0.21 ± 0.5 42.73 ±1.05 6.8 ± 0.05 22.73 ± 1.5 translucent 42 ± 0.5
Note: All experiments were done in triplicate; P value of less than 0.05.
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FIGURE 1 - UV absorption spectra of pure drug and oral dispersible film.
FIGURE 2 - FTIR images of pure drug and various sizes of cellulose mixed Oro dispersible films
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FIGURE 3 - 1H NMR spectra of cellulose mixed ODF (HPMC-F3).
Thermo gravimetric analysis (TGA)
ODF formulations were tested for their thermal 
stability in a range of (200 - 800 ºC) temperature. 
Figure 4 represents the TGA thermo gram of the three 
ODF formulations. This was carried out under nitrogen 
atmosphere with constant heating at a rate of 10 ºC 
(Gaisford et al., 2009). The onset thermal decomposition 
of the film HPMC, MCC-F, NCC-F was observed at 230, 
239 and 274 ºC respectively with a weight loss of 6, 9 
and 13%. This confirms that all ODF formulations were 
showed optimum thermal stability. Final decomposition 
temperature for the three formulations were observed at 
408, 410 and 355 ºC respectively. The thermal stability 
of HPMC contained F3 film was lower due to the weak 
interaction between drug and polymer. The final weight 
loss of ODF formulations were 71, 72.2 and 53% for 
HPMC, MCC-F, and NCC-F respectively. The HPMC 
and MCC-F showed comparatively higher % weight 
loss than NCC-F film. Overall, the thermal stability of 
NCC-F was studied at 274 ºC when compared to HPMC 
and MCC-F formulation.
 Atomic force microscopy (AFM) 
Prepared formulations were examined for surface 
morphology by AFM technique. The AFM topography 
results in different parameters such as average surface 
roughness (Sa), root mean square surface roughness 
(RMS) and maximum peak-valley (Sp-Sv). The 
results of all prepared formulations and their surface 
measurements were mentioned in Table III. The NCC-F 
formulation was showed high porous surface which 
influence the drug release property. From the AFM 
images (Figure 5), NCC-F showed higher surface 
roughness (77.04 nm) than MCC-F (74.65 nm) and F3 
(75.3 nm) and RMS roughness was observed to be 50.265 
nm. These results may help to predict the drug release 
character. Higher surface roughness, more porosity of 
the film may enhance the drug mobility and transport 
characteriestics (Palla-Papavlu et al., 2014). More porous 
and surface roughness may allow water molecules to 
penetrate, which enhance rapid disintegration of drug 
(Scoutaris, 2012).
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FIGURE 4 - TGA thermo gram of HPMC, MCC-F and NCC-F formulation.
TABLE III - Atomic force microscopy parameters for ODF formulations
Formulation Code F1 F2 F3 MCC-F NCC-F
Average surface
roughness (Sa) (nm)
36.833 40.189 75.343 74.654 77.004 
RMS roughness
(Sq) (nm)
47.865 53.177 104.35 89.99 50.265 
Peak-peak height
(Sy) (nm)
411.42 439.47 1315.5 7693.5 679.59 
Maximum peak
height (Sp) (nm)
170.63 200.92 654.82 527.98 186.33 
Maximum peak
Valley depth (Sv) (nm)
-240.78 -238.55 -660.73 -687.11 -493.26
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FIGURE 5 - AFM images of F3, MCC-F and NCC-F formulation.
Scanning electron microscope
Scanning electron microscope (SEM) was 
performed for the prepared formulations to characterize 
its particle size and morphology. Figure 6 represents 
SEM images of formulated ODF. It was showed that F1 
and F2 formulations were rough surface with irregular 
shaped particle sizes, but F3 showed smooth appearance 
with spherical shaped particles. The sizes of particles 
were found to be 30, 37 and 50 µm for F1, F2, and F3 
respectively. From the images the MCC-F, irregular 
and spherical shaped particles were found with unclear 
fragmentation. The average particles size was found 
to be 10 µm. As can be seen from NCC-F images, the 
particles were spherical and clear due to ultrasonic 
treatment. The length of crystals was dependent on ultra-
sonication time and its duration. The average particle 
size of nano-cellulose was 300 nm. The emission of 
heat and excited species via the cavitation effect can 
relax the MCC surface and lead to bond breakages, thus 
the ultrasonic impact will gradually disintegrate the 
micron sized MCC into nano sized NCC (Nishimura 
et al., 2009).
Particle size analyzer 
The results of peak diameter and polydispersity 
index were mentioned in table IV. As mentioned in 
table each value of peak diameter was decreasing with 
increasing ultrasonication time of NCC sample. Sample 
with maximum utrasonication time point 25 min 
(NCC) has lowest peak value (2.1 nm). It is clear from 
Figure 7, that ultrasonication time has direct effect on 
polydspersity of particles in the suspension to reduce the 
particle size.
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FIGURE 6 - SEM images (a) and its enlarged image (b) for NCC-F and F3 formulations.
TABLE IV - Particle size measurement NCC with different ultrasonic time points
Sample name Mean S.D Mode 
NCC 5 min 452.0 nm 56.5 nm 438.2 nm
NCC 10 min 222.2 nm 26.3 nm 224.5 nm
NCC 25 min 2.1 nm 0.3 nm 2.0 nm
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FIGURE 7 - Particle size analyser graphs for NCC polymer at different ultrasonic time points (5 min, 10 min and 25 min).
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Statistical studies
The release mechanism of all the donepezil loaded 
thinfilms were determined by Higuchi model and 
Korsmeyer-Peppas applications as shown in Table V. 
The release kinetics of all the formulations were best suit 
for first order release kinetics. All the formulations were 
shown non-Fickian diffusion and N value were less than 
1. This confirms drug release follows first order kinetics 
and it was mainly depends on disintegration/diffusion 
property of polymer and drug inside the medium.












F 1 0.921 0.864 0.501
F 2 0.754 0.832 0.332
F 3 0.847 0.748 0.415
MCC-F 0.709 0.816 0.337
NCC-F 0.836 0.829 0.407
Note: regression coefficient (r2), diffusional exponent (n) for 
Korsmeyer-Peppas model
In-Vitro drug dissolution studies
Drug dissolution study was conducted to find the 
amount of drug dissolving in the medium at a certain 
point with desirable characteristic behaviour (Choi et 
al., 2012). Digital image of thinfilm is shown in Figure 8. 
In-Vitro dissolution profile data is represented in graph 
(Figure 9). From the results, the drug release pattern of 
various grades of cellulose derivatives were discussed 
and also correlated with the marketed formulation 
(Nagy, 2010). The cumulative percentage drug release 
of all the ODF formulations was increased gradually 
that was indicated in the figure.
FIGURE 8 - Photograph to indicate a transparency of prepared 
ODF
From the figure 9, HPMC formulated film and 
MCC-F has been released promptly upto 42-70% in the 
span of 2.5 min (150 sec). In the period of 5 min (300 
sec), the formulation F1, F2, F3 was released the drug 
upto 56.92, 68.75 and 72.84%. But, 83.48% of the drug 
was released from the formulation MCC-F which was 
quite high in comparison with marketed formulation 
(58.78%). In the case of NCC-F, Drastic drug release 
was achieved directly upto 92.27% in the period of 5 
min (300 sec) without having interval. The 2.1 nm sized 
NCC particle has placed major role which release more 
drug (94.53%) rapidly upto 5 min. Prepared MCC and 
NCC formulations were shown faster drug disintegration 
time and drug release than other formulation which is 
due to nano and micro sizes of polymer present in the 
formulations. From the drug dissolution release graph, 
NCC-F formulation was achieved rapid dissolution 
than HPMC and MCC formulations. This was obtained 
mainly due to less particle size and high disintegration 
property in NCC-F formulation as compared with other 
formulation. These studies proved that nano sized 
hydrophilic cellulose polymers may dissolve freely and 
disintegrate the drug rapidly in the short span of time. 
Rapid drug disintegration of NCC was achieved because 
of higher surface roughness with maximum porous 
(proved from AFM) and the smaller particle size (300 
nm, proved from SEM). Hence, NCC-F formulation 
might be good alternate formulation for elder people 
who diagnosed with Alzheimer’s disease.
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FIGURE 9 - In-vitro dissolution graphs for cellulose combined ODF formulations. All the results mentioned as mean ± SD, n=3.
In vivo animal studies
Selected formulations with optimum physical 
characteristics and better in vitro dissolution behavior 
were conducted for in vivo drug absorption studies 
using male Wister rats. Formulations with HPMC 
5cps (F3), microcrystalline cellulose (MCC-F) and 
nanocrystalline cellulose (NCC-F) were analyzed 
for drug plasma absorption studies with reference 
to marketed oral disintegrating tablets (ODT). 
Administered samples of donepezil (5 mg/kg) 
were evaluated by HPLC method (Abdelbary et al., 
2014). The mean plasma concentration of marketed 
formulation was 16.959 ± 3 ng/mL up to tmax of 4.9 h. 
Mean plasma concentration of NCC-F formulation was 
19.018 ± 5 ng/mL in the span of 4 h and this was higher 
compared to MCC-F formulation. AUC (0-∞) of all 
the formulations were calculated by trapezoid method 
(Tayel et al., 2015). The results of all the formulations 
were shown the tmax in the order of MCC-F < NCC-F 
< F3 < Marketed formulation with values as 3.8, 4.0, 
4.2 and 4.9 h. respectively. The plasma concentration 
in the order of NCC-F > MCC-F > F3 Marketed tablet 
formulation. Significant pharmacokinetic results were 
varied based on the polymer and its size inside the 
matrix/formulation. The total AUC (0-∞) of NCC-F 
formulation was 189.05 ± 13 ng/mL and marketed 
formulation was about 132.05 ± 54 ng/mL. From these 
in vivo data, NCC-F has shown best drug absorption due 
to its particle size 300 nm and surface roughness 77.04 
nm. All the pharmacokinetic data were represented in 
Table VI. The moderate peak plasma concentration 
was observed in the case of MCC-F formulation and 
the total AUC (0-∞) was also near to the marketed 
formulation (169.46 ± 4). The relative bioavailability 
of NCC-F formulation was found to be 143.1% which 
was 40% higher than marketed ODT. The relative 
bioavailability of MCC-F was 127.1 and F3 was 
114.3% which was measured from total area. All the 
formulations were shown optimum pharmacokinetic 
parameters with significant statistical value (p≥0.05). 
From the obtained plasma release graph (Figure 10), 
NCC-F formulation was shown extended t1/2 of 71.1 
h. Based on unique characteristic results obtained 
from physical and pharmacokinetic evaluations, 
NCC-F oral thin film will be best suited and potential 
alternate formulation for the treatment of Alzheimer’s 
diseases. 
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TABLE VI - Plasma concentration (in vivo) and pharmacokinetic parameters of final optimized ODF formulations. Oral 






(0-∞) (ng/mL)  t1/2 (h)
F 3 4.2 ± 2 16.968 ± 5 151.02 ± 12 61.5 ± 53
MCC-F 3.8 ± 2.1 16.946 ± 4 167.95 ± 55 60.3 ± 71
NCC-F 4.05 ± 3 19.018 ± 5 189.05 ± 13 71.1 ± 13
Marketed tablet 4.97 ± 1 16.959 ± 3 132.05 ± 54 55.1 ± 21
Note: Results represented as mean ± SD. (n=4); (p≥0.05)
tmax= Time maximum, Cmax = Concentration maximum, AUC(0-∞) = Area under plasma time curve from 0 h to ∞ h, 
t1/2=Half of the drug concentration at the time 
FIGURE 10 - In vivo bioavailability graph of oral dispersible films of F3, MCC-F, NCC-F with marketed oral disintegrating 
tablet towards male Wister rats, n = 4 and used drug (5 mg/kg) over 24 h. Results represented as mean ± SD, n=4; (p≥0.05)
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CONCLUSION
Oral disintegrating film was designed using 
donepezil hydrochloride mixed HPMC, MCC-F and 
NCC-F for observing rapid drug release property. The 
ODF film was well characterized with spectral (UV, FT-
IR, 1H-NMR) studies and microscopic (AFM and SEM) 
evaluations. Spectral analysis revealed that the hydrogen 
bonding interactions between polymer and drug. From 
the AFM analysis, surface roughness was higher for 
NCC than MCC and HPMC. The prepared ODF was 
achieved optimum thermal stability. Using in vitro 
drug release studies, NCC-F formulation was released 
the drug faster within 5 min on compared with MCC 
and HPMC formulation. In vitro dissolution studies 
and in vivo pharmacokinetic parameters confirmed that 
faster drug disintegration and higher bioavailability was 
achieved in NCC-F formulation than MCC-F, F3 and 
marketed formulations. Overall, nanosized NCC-F is 
best candidate for rapid drug release of Donepezil drug 
in the treatment of Alzheimer’s disease. 
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